Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gentien

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Targeted Oncology|November 20, 2012
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trialChristophe Le Tourneau, Maud Kamal, Olivier Trédan, et al.
Breast Cancer Research : BCR|January 18, 2012
Molecular profiling of patient-derived breast cancer xenograftsFabien Reyal, Charlotte Guyader, Charles Decraene, et al.
Plos One|July 9, 2016
Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage PolarizationDavid Vallerand, Gérald Massonnet, Fatima Kébir, et al.
The Lancet. Oncology|February 11, 2014
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)Fabrice André, Thomas Bachelot, Frederic Commo, et al.
Oncotarget|June 2, 2018
LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancersSylvie Maubant, Tania Tahtouh, Amélie Brisson, et al.
Oncotarget|April 22, 2017
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancersWilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, et al.
Molecular Oncology|February 28, 2023
HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancersRania El-Botty, Sophie Vacher, Juliette Mainguené, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon CancerLaetitia Marisa, Yuna Blum, Julien Taieb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumorsFariba Némati, Xavier Sastre-Garau, Cécile Laurent, et al.
Molecular Oncology|May 26, 2015
TIPIN depletion leads to apoptosis in breast cancer cellsCéline Baldeyron, Amélie Brisson, Bruno Tesson, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Targeted Oncology|November 20, 2012
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trialChristophe Le Tourneau, Maud Kamal, Olivier Trédan, et al.
Breast Cancer Research : BCR|January 18, 2012
Molecular profiling of patient-derived breast cancer xenograftsFabien Reyal, Charlotte Guyader, Charles Decraene, et al.
Plos One|July 9, 2016
Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage PolarizationDavid Vallerand, Gérald Massonnet, Fatima Kébir, et al.
The Lancet. Oncology|February 11, 2014
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)Fabrice André, Thomas Bachelot, Frederic Commo, et al.
Oncotarget|June 2, 2018
LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancersSylvie Maubant, Tania Tahtouh, Amélie Brisson, et al.
Oncotarget|April 22, 2017
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancersWilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, et al.
Molecular Oncology|February 28, 2023
HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancersRania El-Botty, Sophie Vacher, Juliette Mainguené, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon CancerLaetitia Marisa, Yuna Blum, Julien Taieb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumorsFariba Némati, Xavier Sastre-Garau, Cécile Laurent, et al.
Molecular Oncology|May 26, 2015
TIPIN depletion leads to apoptosis in breast cancer cellsCéline Baldeyron, Amélie Brisson, Bruno Tesson, et al.
Pageof 9